The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors.
Citations
2,465 citations
Cites background from "The polyethyleneglycol dilemma: adv..."
...However, PEGylation often compromises the ability of NPs to escape endosomes, which is a required step prior to entering the cell cytoplasm [186]....
[...]
...The “stealth” property endowed by NP PEGylation that minimizes undesired phagocytic clearance can also interfere with the ability of NP to interact with and be internalized by target cells [186, 187]....
[...]
782 citations
698 citations
Cites background from "The polyethyleneglycol dilemma: adv..."
...Acid labile bond cleavage for PEG-detachment Despite the success of ‘stealth’ systems in achieving stability and long-circulation, the major drawbacks of these nanocarriers are poor cellular uptake and slow drug release from endosomes [50, 51], resulting in low bioavailability in the target and compromised drug efficacy [52, 53], known as the PEG dilemma....
[...]
576 citations
Additional excerpts
...between them is requisite to maintain efficacy.[103]...
[...]
523 citations
References
7,494 citations
6,483 citations
5,434 citations
4,572 citations
3,975 citations